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It was recently demonstrated that murine keratinocytes upon 
irradiation with ultraviolet (UV) light release an immuno-
suppressive cytokine which blocks the biological activity of 
interleukin 1 (IL 1). This epidermal ce ll derived inhibitor 
(EC-contra IL 1) exhibits a molecular weight of 40 kD and a 
pI of approximately 9.0. EC-contra IL 1 in vivo possibly may 
penetrate through the basal lamina and subsequently cause 
systemic immunosuppression following UV-exposure. In 
the present study, we tested whether EC-contra IL 1 can also 
be detected in vivo. Serum samples obtained from total body 
UV-exposed mice were subjected to HPLC gel filtration and 
tes ted for IL 1 inhibitory activity. While a non-specific high 
molecular weight (300 kD) suppressor factor was detected in 
sera of both UV -exposed and sham treated control mice, a 
I n vitro and in vivo exposure of epidermal cel ls and macro-phages to ultraviolet (UV) light stimulates their capacity to produce increased levels of interleukin 1 (IL 1) [1- 3], an important mediator of immunity and infl ammation [4J , which also may cause fever and manifestations of an acute 
phase response [5,6J. Recently, it has been demonstrated that UV 
irradiation significantl y enhances IL 1 mRNA expression as well as 
IL 1 release by keratinocytes [7,8J. However, it is also well estab-
lished that chronic UV -exposure of mice leads to local and systemic 
immunosuppression, e.g. , inhibition of the induction of contact 
hypersensitivity [9]. With regard to the loca l immunosuppression 
the main target seems to be the epidermal Langerhans cells which 
loose their anti gen-presenting capacity [10]. The pathomechanisms 
involved in the systemic immunosuppression, however, are not 
quite clear. Very recent observations have demonstrated that normal 
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Abbreviations: 
ConA: conca navalin A 
EC-concra IL 1: epidermal cell derived contra interleukin 1 
HPLC: high performance liquid chromatography 
IL 1: interleukin 1 
IL 2: in tcrleukin 2 
IL 3: interleukin 3 
rIL 1: recombinant interleukin 1 
s-contra IL 1: serum derived contra intcrlcukin 1 
UV: ultraviolet 
specific IL 1 inhibitor exhibiting a molecular weight of 40 
kD was observed only in sera of UV -exposed mice. This 
cytokine named serum-contra IL 1 was maximally released 
24 h after UV -exposure, exhibited a pI of 9.0, and blocked 
the activity of natural as well as recombinant interieukin 1 in 
a dose dependent manner. Serum-contra IL 1 did not suppress 
interieukin 2 or interleukin 3 and did not inhibit spontaneous 
cel l proliferation. The present biochemical and biologic data 
suggest that serum-contra IL 1 and EC-contra IL 1 appear to 
be closely related if not identical. These observations there-
fore indicate that keratinocytes upon UV -irradiation in vivo 
release EC-contra IL 1 which may at least partly be responsi-
ble for the immunosuppression following UV-exposure. ] 
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as well as transformed murine keratinocytes upon UV-exposure 
rel ease a low molecular weight factor which, after intravenous in-
jection, blocks the induction of contact hypersensitivity in the re-
cip ient mouse [11] . In add ition, under identical conditions the same 
cells and cell lines produce a closely· related, if not identical factor, 
which blocks the biologic activity of interleukin 1 specificall y [12J . 
This keratinocyte derived UV -induced inhibitor, named EC-contra 
IL 1, exhibits a molecular weight of 40 kD and a pI of approximately 
9.0. The release of such inhibitory cytokines may at least partly be 
responsible for the systemic immunosuppression following UV-ex-
posure. Because the production of these immunosuppressive factors 
thus far has been detected only in vitro by UV irrad iation of cultured 
keratinocytes, we have investigated whether sera of UV-exposed 
mice contain IL 1 inhibitors possibly related to EC-contra IL 1. 
MATERIAL AND METHODS 
Animals Specific pathogen free Balb/c female mice were supplied 
by the Versuchstierzuchtanstalt Himberg, Austria. All animals were 
10 - 12 weeks old at the time of experiments. 
UVB-irradiation of Animals A single 3-h exposure (1 X 104J/ 
1112) of UVB light was administered from a bank of TL 12 lamps 
(Philips, Eindhoven) which delivered an average dose rate of 0.9 
J/m2/s to the shaved dorsal surface of the mice. Control animals 
were treated exactly as the irradiated mice except for the exposure to 
UV light. 3, 6,12,24,48, or 72 h later blood was obtained by heart 
puncture under anesthesia. The blood was allowed to clot 30 min, 
tben centrifuged at 1000 g for 10 min. Serum samples were imme-
diately subjected to HPLC fractionation or stored at -20°C. 
Cytokines and Bioassays Murine IL 1 was prepared by incubat-
in g Pam 212 ce lls at a density of 1 X 106 cells/ml in serum free 
RPMI 1640 medium for 48 h, as described [13]. Murine recombi-
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nant IL 1 (rIL 1) was a generous gift from Dr. Lomedico (Hoffman 
La Roche, Nutley, NJ). Recombinant murine interleukin 2 (IL 2) 
vo.:as obtamed from Genzyme Corp. (Boston, MA). Murine interleu-
km 3 (IL 3) was prepared from the monomyelocytic cell line Wehi 3 
as described [1.4]. ~or the detection of IL 1 activity, samples were 
assayed for their abtllty to enhance ConA-mediated proliferation of 
thymocytes from C3H/He mice or to induce proliferation of the 
murine hel(>er! ~ell iine DlO.G4.1, as described [13,15]. In order 
to evaluate lJlhlblt10n of IL 1 activity, samples were tested in the 
presence of natural or recombinant murine IL 1 (1 U /ml). Results 
,:"e~e .express~d either as cpm ± SEM of triplicate cultures or as 
mhlbltory Ul11ts which were calculated as the reciprocal dilution of 
50% inhibition of 1 U/ml IL 1 X 10. 
~~rum samples were tested for IL 2 inhibitory activity by their 
a.bdlty to bloc~ the proliferation of an IL 2-dependent murine T-cell 
Im~ ~CTLL) 111 the presence of IL 2 (2 U /ml). IL 3 inhibitory 
activity was evaluated by using an IL 3-dependent cell line (32 
DCL) in the presence oOL 3 (50 U /ml). 
Size Exclusion High-performance Liquid Chromatography 
(HPLC) Samples (100 Ill) were subjected to a size-exclusion col-
umn (Bio-Sil TSK 125, 300 X 7.5 O1m Bio-Rad) and elution was 
carned out with PBS (pH 7.2) at a flow rate of 1.0 ml/min. 
HPLC Chromatofocusing Chromatofocusing was done with a 
Mono-P prepacked column (HR 5/20, 5 X 200 mm, Pharmacia, 
Uppsala, Sweden) equilibrated in 0.025 M imidazole HCI buffer 
(p~ 9.5). Elution was carried out with a polybuffer/HCI at pH 5.5 
(BlO Rad), USlJlg a flow rate of 1.0 ml/min. The actual pH in each 
fraction was determ.ined with a pH meter. 
RESULTS 
Detection of IL 1 inhibitors in the sera of UVB-treated mice was 
achi~ved by testing serum samples obtained 24 h after UVB expo-
sure Il1 the thymocyte co-stimulator assay in the presence of natural 
munne IL 1 (1 U /ml). Because of the well-known fact that serum of 
UV-irrad~ated mice does conta~n il?c.reased levels of IL 1 and possi-
bly a vanety of non-speCific mll1bltors, serum was subjected to 
HPLC gel filtration before testing for IL 1 inhibition. A significant 
suppression of IL 1 activity was found in sera of both UV -exposed 
and untreated control mice in the high molecular weight range at 
about 300 .kD (~ig 1). In sera ofUVB exposed mice, however, an 
addltlOnal 1l1111bltory peak was observed eluting at about 40 kD thus 
appearing in the same molecular weight range as EC-contra'IL 1 
[12]. In contrast to the high molecular weight IL 1 inhibitor, the 40 
kD suppressor factor was not detectable in unirradiated control 
mice, suggesting that UV-Iight induces the re lease of a cytokine 
which suppresses the proliferation of murine thymocytes induced 
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Figure 1. HPLC gelli ltration (TSK 125) of serum derived from UV-ex-
posed mice (e- e) or untreated control animals (.t.- - -.t.). Fractions were 
tested in the thymocyte assay after addition of 1 U / ml natural murine 
interleukin 1. 
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Figure 2. HPLC gel filtration fractions (40 kD) of serum obtained 24 h 
after UV-irradiation. Fractions were tested at different dilutions for IL 1 
inhibitory activity in the thymocyte assay after addition of 1 U Im l recombi-
nant murine interleukin 1. 
by natural as well as recombinant IL 1 in a dose dependent manner 
(Fig 2). 
In order to detect the maximum release of the 40 kD IL 1 inhibi-
tor, subsequently referred as "serum-contra IL I" (s-contra IL 1), we 
tested sera obtained 3, 6, 12, 24, 48 or 72 h after UV exposure for 
biological activity in the 40 kD fractions. Minimal IL 1 suppression 
was observed in sera taken 3 h after irradiation, and inhibitory activ-
ity increased steadily to a peak 24 h after UV exposure (Fig 3). 
Therefore in the subsequent experiments only serum withdrawn 24 
hr after UV irradiation was used, unless otherwise stated. 
Because the thymocyte proliferation assay involves a heterog-
enous cell population and thus the blocking effect of s-contra IL 1 
could be indirect, the murine helper T-cell line DIO.G4.1 was used 
as a test system for IL 1 blocking activity. The 300 and 40 kD serum 
fractions were added at various dilutions to the DI0 assay in the 
presence of recombinant murine IL 1. In a manner identical to the 
thymocyte assay, DI0 proliferation was significantly blocked after 
addition of both the high and low molecular weight fractions 
(Table I) . 
To investigate whether the inh:bitory capacity of serum suppres-
sor factors is specific for IL I, we studied their effect on the activity 
oEIL 2 and IL 3. Therefore, the 300 or 40 kD fractions were added at 
various dilutions to IL 2 and IL 3 bioassays in the presence of IL 2 
and IL 3, respectively. Addition of the high molecular weight frac-
tions significantly blocked the IL 2 induced proliferation of CTLL 
cells as well as the IL 3 driven proliferation of 32 DCL cells, thus 
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Figure 3. Time kinetics of the release of s-colltra IL 1. HPLC gel filtration 
fractions (40 kD) of serum obtained 3, 6,12,24,48, or 72 h were tested for 
IL 1 inhibitory activity in the thymocyte assay after addition of 1 U / m] 
recombinant murine interleukin 1. 
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Table I. Effect of Serum-IL 1 Inhibitors on IL 1, IL 2, and IL 3 Activity 
RPMI 
40 kD fractiond 
300 kD fraction' 
a Recombinant murine IL 1. 
b Recombinant murine Il 2. 
IL 1 activity + IL l' 
(1 u/ml) 
9,792 ± 399( 
4,812 ± 800 
3,156 ± 93 
, Supernatant of WEHI 3 cell s cu ltured for 48 h. 
IL 2 activity + IL 2b 
(2 u/ml) 
14,953 ± 354' 
13,761 ± 463 
3,412 ± 159 
IL 3 activity + IL 3' 
(50 u/ml) 
17,761 ± 618" 
15,109 ± 417 
4,901 ± 121 
d Pooled 40 kD HPLC gel filtration fractions of serum from UV irradiated mice. 
, Pooled 300 kD HPLC gcl filtration fractions of serum from UV irradiated mice. 
f IL 1 activity was eva luated by using the D10 assay. Results arc expressed as mean cpm ± SE of triplicate cultures . 
• Il 2 activity was evaluated by using an IL 2.dependent CTLL. Results arc expressed as mean cpm ± SE of triplicate cultures. 
h Il 3 activity was evaluated by using an Il 3·dependent cell line (32 DCl). Results arc expressed as mean cpm ± SE of triplicate cultures. 
indicating that the high molecular weight inhibitor represents a 
non-specific suppressor factor (Table I) . In contrast, the 40 kD 
fractions blocked neither IL 2 nor IL 3 activity, suggesting that 
s-contra IL 1 seems to be a specific inhibitor ofIL 1 activity. In order 
to rule out a non-specific interference of s-contra IL 1 with murine 
thymocytes, we evaluated the effect on the spontaneous prolifera-
tion of several cell lines such as Pam 212 and EL 4. Addition of 
s-contra IL 1 did not suppress the 3H-thymidine incorporation de-
tected after an incubation period of 48 h thus ruling out the possibil-
ity that this suppressor factor is a non-specific inhibitor of DNA-
synthesis (Table II). 
For the further biochemical characterisation of s-contra IL 1, sera 
derived from UV exposed mice were subjected to HPLC chromato-
focusing. When a linear pH gradient from 5.5 to 9.5 was applied 
two IL 1 inhibitory peaks were detected at pH 9.0 and 7.0, respec-
tively (Fig 4). Upon subsequent HPLC gel filtration, the IL 1 inhib-
itor with a pI of9.0 was found to have a molecular weight of 40 kD, 
while the fractions with pI 7.0 eluted in the high molecular weight 
range (Fig 5). These data demonstrate that s-contra IL 1 exhibits a 
molecular weight of 40 kD and a pI of 9.0, thusshowing a close 
similarity to EC-contra IL 1 [12]. 
DISCUSSION 
The present study demonstrates that UV irradiation of mice induces 
the release of a specific interleukin 1 inhibitor. When unfraction-
ated serum samples obtained from irradiated or sham treated control 
mice were tested for IL 1 inhibition, a strong suppression of thymo-
cyte proliferation was observed (data not shown). Because the inhi-
bition was even beyond the ConA background in some eX'peri-
ments, one possibility is that this effect is due to non-specific 
suppressor factors. When sera were subjected to HPLC gel filtra-
tion, the subsequent data clearly demonstrated that sera ofUVB-ir-
radiated Balb/c mice contain a specific inhibitor ofIL 1, which was 
named "serum-contra IL 1" (s-contra IL 1). In the present study 
s-contra IL 1 was detected only in UVB-exposed mice. However, 
whether the release is specific for UV light or can also be induced by 
Table II. Lack of Effect of Serum-contra IL 1 on Spontaneous 
Proliferation of Different Cell Lines' 
Serum-contra.IL 1 b Pam 212 EL4 
RPM! 2,617 ± 813 4,718 ± 591 
1 :4 2,187 ± 461 5,317 ± 509 
1: 8 2,470 ± 663 5,118 ± 444 
1: 16 2,715 ± 175 4,199 ± 687 
1 :32 1,988 ± 976 4,612 ± 263 
1:64 2,335 ± 193 5,418 ± 186 
• Cells (5 X 10') were cultured in RPMI 1640 supplemented with 5% FCS and 
various dilution of serum·contra·IL 1. After 30 h incubation at 37'C in a humidified 
atmosphere containing 5% CO2 , cells were pulsed for the final 16 h ('H) thymidine (0.5 /lei / well) and were harvested; radioactivity was measured by using a liquid scintil· 
lation counter as described. Results are expressed as mean ±SE of triplicate cultures. 
b Pooled activity (40 kD) of HPlC gel filtration. 
other events, such as thermal injury, cannot be answered at the 
moment. In addition, the mode of action of this inhibitor is not yet 
clear: s-contra IL 1 may represent a competitive inhibitor ofIL 1. 
However, this speculation is based only on preliminary observations 
that increasing amounts of IL 1 can overcome the inhibitory activ_ 
ity. 
At present it is not known exactly which cells are the source of 
s-contra IL 1. Although this study does not provide formal evidence 
one might assume that s-contra IL 1 may be keratinocyte derived 
because this inhibitor exhibits biochemical and biologic features 
that appear to be similar to that of keratinocyte-derived EC-contra 
IL 1. Both cytokines elute in the same molecular weight range (40 
kD) and have a similar pI (9.0). Moreover, both factors have to be 
induced by UVB-light, block natural and recombinant murine IL 1 
in a dose dependent manner, and appear to be specific for IL 1 
because other cytokines such as IL 2 and IL 3 are not affected. In the 
present study the thymocyte co-stimulator assay was used for detec-
tion of IL 1 inhibition. Because t~e murine thymocyte assay in-
volves a heterogenous cell population, and thus the inhibitory activ-
ity of s-contra IL 1 could be indirect, in some experiments the 
murine D10.G4.1 cell line, a helper T cell clone, was used and 
demonstrated identical results. However, future work with s-colltra 
IL 1 must address whether it blocks IL 1 effects not involving T-cell 
activation, such as release of acute phase proteins, induction offever, 
or granulocytosis. 
In vivo exposure to UVB-light leads to cutaneous inflammation, 
the release of acute phase proteins, malaise, chills, somnolence, and 
fever, which also have been shown to be at least partly mediated by 
IL 1 [16] . In addition it has been demonstrated that UVB irradiation 
induces the release of IL 1 in vivo and in vitro, and increased serum 
IL 1 activity has been detected in UV -exposed mice and rabbits [2,16] . 
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Figure 4. HPLC chromatofocusing upon a Mono P prepacked column of 
serum obtained 24 h after UV-exposure. Elution was carried out with poly-
buffer/HCI, pH 5.5 at a flow rate ofl.0 ml/min. Actual pH (0-0-0-0) was 
detected in each fraction . Column fractions were tested in the thymocyte 
assay after addition of 1 U /ml interleukin 1. 
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Figure 5. HPLC gel filtration (TSK 125) of pooled chromatofocusing 
fract ions. Chromatofocusing fractions eluting at pH 9.0 (A- - -A) and at pH 
7.0 (e-e) were pooled and subjected to HPLC gel filtration. Fractions 
were tested for IL 1 inhibitory activity in the thymocyte assay after addition 
of 1 U/ml recombinant murine interleukin 1. 
Thus the detection of an IL 1 inhibitor in serum of UVB-treated 
mice in this study appear's surprising. This phenomenon may be part 
of a physiologic feedback mechanism turning down the biologic 
effects of IL 1. Maximum release of s-contra IL 1 has been observed 
24 to 48 h after UV-exposure. Previous studies, however, have 
shown that serum peaks of IL 1 activity are also detected 24 to 48 h 
post UV irradiation [2). Although these studies cannot be compared 
directly due to different experimental conditions, the simu ltaneous 
release of IL 1 and its inhibitor is unexpected, because in feedback 
mechanisms th e inhibitor usually is maximally released later than its 
ligand. Gahring et aI, however, demonstrated increased circulating 
levels oOL 1 in chronica lly UV exposed animals, although no direct 
biologic effects of IL 1 could be observed in these animals [2). This 
"desensitization" may possibly be due to a down regulation of target 
cell surface receptor density, a depression of receptor affinity for 
ligand, or an e levation of specific inhibitors for IL 1. The detection 
of s-contra IL 1 supports the latter hypothesis. 
In addition to s-contra IL 1, sera also contain a strong inhibitor of 
IL 1 eluting at about 300 kD. This suppressive activity was more 
pronounced than that of s-contra IL 1. In contrast to s-contra IL 1, 
which had to be induced by UVB-light, the high molecular weight 
inhibitor cou ld also be demonstrated in sera obtained from un-
treated control mice. This cytokine also blocks IL 2 and IL 3 signifi-
cantly and thus represents a non-specific suppressor factor inhibit-
ing the bioassays by toxic effects. Therefore, this factor was not 
further characterized. 
A variety of IL 1 inhibitors have been described recently, mostly 
in the urine of febril e or pregnant patients [17,18). These immuno-
suppressors appear to be heterogenous and exhibit different block-
ing capacities, and thus the in vivo implications have not been 
determined yet. Moreover, none of these factors has been purified to 
homogeneity so far, and the relation to other suppressive cytokines 
is not yet settled. 
Because measurement ofIL 1 and inhibitory activ ities in biologic 
fluids depends on bioassays and requires partial purification for re-
moval of substances that interfere with cell proliferation non-spe-
cificall y, few data on the in vivo production oflL 1 inhibitors exist 
[19). Recently Prieur et al have observed a specific IL 1 inhibitor in 
sera and urine of children with systemic juvenile chronic arthritis 
[19). Although this factor has not been biochemically characterized, 
the existence of such a mediator may be important in the under-
standing of the pattern of fever in this disease. 
In addition to these in vivo data, the release ofIL 1 inhibitors has 
been observed in vitro in virus infected human macrophages [20), 
virus transformed B-cell lines [21), human endothelial cells [22), 
granu locytes [23), and epithelial cells [1 2,24]. The biologic in vivo 
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functions of these heterogenous factors are not yet clear and there 
seems to be no relationship between most of these mediators and 
s-contra IL 1. S-contra IL 1 and EC-contra IL 1, however, are bio-
logically and chemically closely related, if not identical, thus sup-
porting the view that keratinocytes are the main source of s-contra 
IL 1. The detection of an IL 1 inhibitor in the serum which appears 
to be related to EC-contra IL 1 confirms the speculation that the 
production ofEC-contra IL 1 by keratinocytes is not only an in vitro 
phenomenon but might also be of biologic in vivo significance. The 
present data thus support the hypothesis that epidermal cells release 
EC-contra IL 1 upon UVB irradiation, which penetrates the basal 
lamina, enters the circu lation, and probably causes systemic immun-
osuppressive effects. 
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Vasculitis, Androgenetic Alopecia, Pemphigus and Pemphigoid, the Pigmentary System in-
cluding Vitiligo. Melanoma, Principles and Practical Aspects of Dermatologic Surgery, Oral 
Lesions, Nail Surgery. and Skin Eruptions of Pregnancy. 
LANGUAGE: The officallanguage of the Symposium will be English. 
SYMPOSIUM FEES: North American Participants. $425 U.S. North American accompan-
ing person, $200 U.S. Participants for other locations, contact Chinese Committee Chair-
man. 
Space is being reserved on the program for attendees to present 15- to 20-minute papers. 
These will be selected by the program committee from among all papers submitted. Authors 
intending to submit abstracts to be considered for presentation are requested to complete the 
reply form and return it as soon as possible. Abstracts should be no more than 200 words typed 
and double spaced. It should be sent in triplicate to the appropriate committee chairman no 
later than February 1. 1989. The China Association for Science and Technology will publish 
accepted abstracts after any necessary editing. 
For further information contact: Marcia Wennberg, International Foundation for Scholarly 
Exchange. 1-800-633-4734. 
